Upcoming events

Fragment-Based Lead Discovery Conference

In person

This year, the FBLD Conference takes place in Boston, and ZoBio is excited to be part of this remarkable event. Fragment-Based Lead Discovery (FBLD) continues to grow rapidly as a multidisciplinary field, bringing together experts in chemistry, biochemistry, and related areas to present the latest advancements.

Gregg Siegal, CEO of ZoBio, looks forward to connecting with the FBLD community and participating in a high-quality program featuring talks, workshops, poster sessions, and numerous networking opportunities, all centered around the diverse aspects of fragment-based drug discovery.

Discovery on Target

In person

Our team is excited to participate in Discovery on Target, the industry’s premier event focused on novel drug targets and cutting-edge technologies for drug discovery professionals. The conference will showcase the latest advancements in both current and emerging “hot” targets, as well as innovative target validation strategies for developing novel therapeutic agents, from biologics to small molecules.

Masa Kobayashi, Head of Assay Development and Screening, will present the poster titled Site Selective Screening: Using Biophysics to Define a Mode of Action. Contact Masa to find out how can we use SPR in your project!

BioJapan 2024

In person

For the first time, ZoBio is excited to participate in BioJapan 2024, an event held in conjunction with Regenerative Medicine Japan and healthTECH Japan. As Asia’s largest partnering event, it offers a comprehensive platform through its three main programs: exhibition, seminars, and partnering.

Jan Schultz will be attending One-on-One meetings to share insights about our services and recent developments at ZoBio and ODS with other participants.

15th Swiss Course on Medicinal Chemistry in Leysin

In person

As in previous years, ZoBio is proud to be a sponsor of the 15th Swiss Course on Medicinal Chemistry in Leysin!

This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting methodologies and technologies that support hit generation, lead finding, and lead optimization campaigns.

The course content is tailored for young scientists working in medicinal chemistry, as well as those from related disciplines such as biochemistry, pharmacy, pharmacology, or biophysics, from both the pharmaceutical and biotech industries.

ZoBio is excited to contribute to this special event. On Thursday, October 17th, our scientist Stephan Theisgen will present a talk on the application of NMR in modern drug discovery. Additionally, Marta Carneiro (Head of Structural Biology) and Johan Veerman (Head of Chemistry) will share their expertise on the use of biophysics in various aspects of drug discovery with the next generation of drug hunters.

We are confident it will be another unforgettable event!

Past events

Developments in Protein Interaction Analysis (DiPIA 2024)

In person

From September 9 to 12, Welmoet de Winter, one of our scientists, was attending the DiPIA conference in Uppsala, Sweden. DiPIA, or Developments in Protein Interaction Analysis, is a global scientific conference hosted by Cytiva. This event brings together industry peers to share best practices, research, and new applications in the field. The conference is specifically dedicated to surface plasmon resonance (SPR) technology, as featured in our Biacore™ SPR systems.

The theme for this year’s DiPIA was Exploring the Unknown, focusing on the past, present, and future of scientific exploration.

Welmoet presented the poster: Mechanism of action: selective screen of small molecules by SPR. She truly enjoyed the vibrant exchange of knowledge and innovation at this great event.

XXVII EFMC International Symposium on Medicinal Chemistry

In person

ZoBio was present in Rome for the XXVIII EFMC International Symposium on Medicinal Chemistry.

The 2024 program promised to be as interesting and diverse as ever, covering significant advances in drug discovery across major therapeutic areas and it truly was. Key topics included bacterial and viral infections, as well as neurodegenerative and cardiovascular diseases, rare diseases, and cancer.

The conference highlighted the latest breakthroughs in new technologies, such as the targeting of RNA as a drug, the role of artificial intelligence in drug discovery, natural product-based drug discovery, DNA-encoded libraries, and the development of covalent drugs, PROTACs, and molecular glues.

Alongside our sister company, Oncodesign Services, we enjoyed many interactions at our booth and learned a lot from many inspiring medicinal chemistry stories that were shared!

Advancing Drug Discovery with Innovative Science and Technologies

In person

ZoBio was delighted to participate in one of the prestigious Gordon Research Conferences (GRC) which is a premier, international scientific conference dedicated to advancing the frontiers of science. This year the conference took place in New London, New Hampshire.

The conference program featured a diverse array of speakers and discussion leaders from leading institutions and organizations worldwide, all focused on the latest developments in the field of medicinal chemistry. This dynamic environment promoted the exchange of innovative ideas and collaborative efforts.

Gregg Siegal presented a poster titled Biophysical Approaches to Molecular Glue Discovery. It highlighted ZoBio’s innovative strategies and methodologies in the discovery of molecular glues, showcasing the company’s expertise and capabilities in this specialized area of drug discovery.